Postoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234

PURPOSE: To report results of a randomized phase II trial (Radiation Therapy Oncology Group RTOG-0234) examining concurrent chemoradiotherapy and cetuximab in the postoperative treatment of patients with squamous cell carcinoma of the head and neck (SCCHN) with high-risk pathologic features. PATIENT...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Harari, Paul M., Harris, Jonathan, Kies, Merrill S., Myers, Jeffrey N., Jordan, Richard C., Gillison, Maura L., Foote, Robert L., Machtay, Mitchell, Rotman, Marvin, Khuntia, Deepak, Straube, William, Zhang, Qiang, Ang, Kian
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2014
Soggetti:
ORIGINAL REPORTS
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4121506/
https://ncbi.nlm.nih.gov/pubmed/25002723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.53.9163
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi